Same Wilson disease CONTRAINDICATION. More GI irritation than chelated forms. Higher risk of GI toxicity at comparable doses. Prefer organic forms for supplementation.
Inorganic copper salt. Lower bioavailability than organic forms. Industrial and agricultural use predominates. Pharmaceutical use for copper deficiency treatment.
Acts on cellular signalling pathways relevant to the documented clinical indications. Contains bioactive compounds with enzyme-modulating, receptor-binding, or antioxidant properties studied in peer-reviewed literature.
| Population | Safety rating | Max safe dose |
|---|---|---|
| General | Possibly safe | — |
| Pregnancy | Possibly safe | — |
| Elderly | Possibly safe | — |
No peer-reviewed clinical trial data found for this ingredient.
Data by supplement.ge — Public Health Institute of Georgia (PHIG)